Defining the Completion of Translation by Clinical Implementation
Abstract：At the beginning of 2026, China's translational medicine is entering a new phase characterized by 'emphasis on change' rather than just 'output'. With policy guidance and sustained investment, achievements such as papers, patents, prototypes, and platforms are accumulating rapidly, and the foundational conditions for innovation have significantly improved. However, in my view, the key to translational medicine is not only 'developing technology and forming intellectual property', but also whether innovative results can be adopted in clinical settings, undergo evidence-based evaluation, and be integrated into real-world clinical scenarios through standardized processes, thereby rewriting treatment pathways and improving patient outcomes. If we compare innovation to a beam of light, lighting the laboratory is just the beginning; only by directing that light toward wards and outpatient clinics, illuminating real clinical needs, can we truly test the 'completion' of translation.
Machine-generated Keywords：
Publication Date：2026-01-20
Online Publishing Date：2026-01-24(First online date of this platform, not the publication date of the document)
Pages：2( 封2,前插1 )